1Suppliers
0Customers
1Debt Items
0Related Chains

Instil Bio, Inc. Suppliers

TickerNameConfidenceEvidence
IMMUNEONCO-BIOPHARMACEUTICALS-SHANGHAI-INC IMMUNEONCO-BIOPHARMACEUTICALS-SHANGHAI-INC 92% As part of the IO Collaboration Agreement, Axion Bio made a $ 10.0 million upfront payment to ImmuneOnco during the year ended December 31, 2024.

Instil Bio, Inc. Customers

No clients on recordNo downstream customers found in our database for Instil Bio, Inc..

Instil Bio, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
TIL-DEBT-12984 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.

Instil Bio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Instil Bio, Inc..

Instil Bio, Inc. Ownership

HolderNameConfidenceEvidence
TIL-OWNER-BML-CAPITAL-MANAGEMENT-LLC BML Capital Management, LLC 90% 13F overlay lists BML Capital Management, LLC as top holder; 31 tracked holders.

Instil Bio, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.